132 related articles for article (PubMed ID: 15730606)
1. Failure of nasogastric omeprazole suspension in pediatric intensive care patients.
Haizlip JA; Lugo RA; Cash JJ; Vernon DD
Pediatr Crit Care Med; 2005 Mar; 6(2):182-7. PubMed ID: 15730606
[TBL] [Abstract][Full Text] [Related]
2. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Balaban DH; Duckworth CW; Peura DA
Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole.
Yildizdas D; Yapicioglu H; Yilmaz HL
J Crit Care; 2002 Dec; 17(4):240-5. PubMed ID: 12501151
[TBL] [Abstract][Full Text] [Related]
4. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.
Phillips JO; Metzler MH; Palmieri MT; Huckfeldt RE; Dahl NG
Crit Care Med; 1996 Nov; 24(11):1793-800. PubMed ID: 8917027
[TBL] [Abstract][Full Text] [Related]
6. Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial.
Ortiz JE; Sottile FD; Sigel P; Nasraway SA
Pharmacotherapy; 1998; 18(3):486-91. PubMed ID: 9620099
[TBL] [Abstract][Full Text] [Related]
7. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls.
Kuo B; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1532-8. PubMed ID: 8759656
[TBL] [Abstract][Full Text] [Related]
8. Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
Kaufman SS; Lyden ER; Brown CR; Davis CK; Andersen DA; Olsen KM; Bergman KL; Horslen SP; Sudan DL; Fox IJ; Shaw BW; Langnas AN
J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):194-8. PubMed ID: 11840039
[TBL] [Abstract][Full Text] [Related]
9. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
10. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Javsicas LH; Sanchez LC
Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.
Conrad SA; Gabrielli A; Margolis B; Quartin A; Hata JS; Frank WO; Bagin RG; Rock JA; Hepburn B; Laine L
Crit Care Med; 2005 Apr; 33(4):760-5. PubMed ID: 15818102
[TBL] [Abstract][Full Text] [Related]
12. 0.5 mg/kg versus 1 mg/kg of intravenous omeprazole for the prophylaxis of gastrointestinal bleeding in critically ill children: a randomized study.
Solana MJ; López-Herce J; Sánchez A; Sánchez C; Urbano J; López D; Carrillo A
J Pediatr; 2013 Apr; 162(4):776-782.e1. PubMed ID: 23149178
[TBL] [Abstract][Full Text] [Related]
13. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
Bishop J; Furman M; Thomson M
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of upper gastrointestinal bleeding in mechanically ventilated children.
Deerojanawong J; Peongsujarit D; Vivatvakin B; Prapphal N
Pediatr Crit Care Med; 2009 Jan; 10(1):91-5. PubMed ID: 19057446
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
17. [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].
Orsi M; Donato G; Busoni V; Naisberg G; Caruso N
Acta Gastroenterol Latinoam; 2011 Jun; 41(2):111-8. PubMed ID: 21894724
[TBL] [Abstract][Full Text] [Related]
18. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
Ono S; Kato M; Ono Y; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
Endoscopy; 2009 Apr; 41(4):299-303. PubMed ID: 19340731
[TBL] [Abstract][Full Text] [Related]
19. Plasma aluminum concentrations in long-term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate.
Tryba M; Kurz-Müller K; Donner B
Crit Care Med; 1994 Nov; 22(11):1769-73. PubMed ID: 7956280
[TBL] [Abstract][Full Text] [Related]
20. Use of methylene blue spectrophotometry to detect subclinical aspiration in enterally fed intubated pediatric patients.
Kamat P; Favaloro-Sabatier J; Rogers K; Stockwell JA
Pediatr Crit Care Med; 2008 May; 9(3):299-303. PubMed ID: 18446103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]